- Home
- CRNC vs CVRX Comparison
CRNC vs CVRX Comparison
Compare CRNC & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNC
- CVRX
- Stock Information
- Founded
- CRNC 2020
- CVRX 2000
- Country
- CRNC United States
- CVRX United States
- Employees
- CRNC N/A
- CVRX N/A
- Industry
- CRNC EDP Services
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CRNC Technology
- CVRX Health Care
- Exchange
- CRNC Nasdaq
- CVRX Nasdaq
- Market Cap
- CRNC 445.8M
- CVRX 419.8M
- IPO Year
- CRNC N/A
- CVRX 2021
- Fundamental
- Price
- CRNC $9.29
- CVRX $4.77
- Analyst Decision
- CRNC Buy
- CVRX Buy
- Analyst Count
- CRNC 8
- CVRX 7
- Target Price
- CRNC $9.38
- CVRX $14.50
- AVG Volume (30 Days)
- CRNC 902.1K
- CVRX 370.8K
- Earning Date
- CRNC 05-07-2025
- CVRX 05-08-2025
- Dividend Yield
- CRNC N/A
- CVRX N/A
- EPS Growth
- CRNC N/A
- CVRX N/A
- EPS
- CRNC N/A
- CVRX N/A
- Revenue
- CRNC $254,250,000.00
- CVRX $52,870,000.00
- Revenue This Year
- CRNC N/A
- CVRX $22.17
- Revenue Next Year
- CRNC $9.23
- CVRX $24.02
- P/E Ratio
- CRNC N/A
- CVRX N/A
- Revenue Growth
- CRNC N/A
- CVRX 25.62
- 52 Week Low
- CRNC $2.34
- CVRX $5.81
- 52 Week High
- CRNC $27.50
- CVRX $18.55
- Technical
- Relative Strength Index (RSI)
- CRNC 52.58
- CVRX 28.07
- Support Level
- CRNC $8.70
- CVRX $7.30
- Resistance Level
- CRNC $10.44
- CVRX $7.91
- Average True Range (ATR)
- CRNC 0.71
- CVRX 0.56
- MACD
- CRNC 0.13
- CVRX 0.12
- Stochastic Oscillator
- CRNC 64.51
- CVRX 4.36
About CRNC Cerence Inc.
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.